Host genetic polymorphisms in human immunodeficiency virus–related neurologic disease

References

• Bioque G, Crusius JBA, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SGM, Pena AS (1995). Allelic polymorphism in IL-1beta and IL-1 receptor antagonist (IL-1Ra) genes ininflammatory bowel disease. Clin Exp Immunol 102: 379–383.
   PubMed Web of Science ®Google Scholar
• Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW (1994). Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37: 1380– 1385.
   Google Scholar
• Chapman J, Estupinan J, Asherov A, Goldfarb LG (1996). A simple and efficient method for apolipoprotein E genotype determination. Neurology 46: 1484– 1485.
   Google Scholar
• Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewcyk K, Birnbau M, Michaelson DM, Korczyn AD (2001). APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 56: 312–316.
   PubMed Web of Science ®Google Scholar
• Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59: 1563–1567.
   PubMed Web of Science ®Google Scholar
• Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607– 613.
   Google Scholar
• Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C (1998). HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4: 1182–1184.
   PubMed Web of Science ®Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261: 921–923.
   PubMed Web of Science ®Google Scholar
• Crucius JBA, Pena AS, van Osten BW, Bioque G, Garcia A, Dijkstra CD, Polman CH (1995). Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 346: 979–980.
   Google Scholar
• Danis VA, Millington M, Hyland VJ, Grennan D (1995). Cytokine production by normal humanmonocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99: 303–310.
   PubMed Web of Science ®Google Scholar
• de la Concha EG, Arroyo R, Crusius JBA, Campillo JA, Martin C, Varela de Seijas E, Pena AS, Claveria LE, Fernandez-Arquero M (1997). Combined effect of HLADRB1*1501 and interleukin-1 receptor antagonist allele 2 in susceptibility to relapsing-remitting multiple sclerosis. J Neuroimmunol 80: 172–178.
   Google Scholar
• Dunlop O, Goplen AK, Liestol K, Myrvang B, Rootwelt H, Christopherson B, Kvittingen E-A, Maelen J (1997). HIV dementia and apolipoprotein E. Acta Neurol Scand 95: 315–318.
   PubMed Web of Science ®Google Scholar
• Emahazion T, Jobs M, Howell WM, Siegfried M, Wyoni P-I, Prince JA, Brookes AJ (1999). Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways. Gene 238: 315–324.
   PubMed Web of Science ®Google Scholar
• Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schifermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R (2001). Apolipoprotein E4 is associated with rapid progression of multiple sclerosis. Neurology 57: 853–857.
   PubMed Web of Science ®Google Scholar
• Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Ben Yehuda A, Groswasser Z (1999). Apolipoprotein E-epsilon4 genotype predicts a poor outcome insurvivors of traumatic brain injury. Neurology 52: 244–248.
   PubMed Web of Science ®Google Scholar
• Gelman BB, Dholakia S, Casper K, Kent TA, Cloyd MW, Freeman D (1996). Expansion of the cerebral ventricles and correlation with acquired immunodeficiency syndrome neuropathology in 232 patients. Arch Pathol Lab Med 120: 866–871.
   Google Scholar
• Goldstein DB (2001). Islands of linkage disequilibrium. Nat Genet 29: 109–111.
   PubMed Web of Science ®Google Scholar
• Griffin DE (1997). Cytokines in the brain during viral infection: clues to HIV-associated dementia. J Clin Invest 100: 2948–2951.
   Google Scholar
• Huang S-L, Su C-H, Chang S-C (1997). Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 156: 1436–1439.
   PubMed Web of Science ®Google Scholar
• Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S (1997). Apolipoprotein E ε4 associated with chronic traumatic brain injury in boxing. J Am Med Asso 278: 136–140.
   PubMed Web of Science ®Google Scholar
• Lander ES, Kruglyak L (1995). Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241–247.
   PubMed Web of Science ®Google Scholar
• Lipton SA (1998). Neuronal injury associated with HIV-1: approaches to treatment. Ann Rev Pharmacol Toxicol 38: 159–177.
   PubMed Web of Science ®Google Scholar
• Lucotte G, Loirat F, Hazout S (1997). Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe. Hum Biol 69: 253–262.
   PubMed Web of Science ®Google Scholar
• Mansfield JC, Holden H, Tarlow JK, Francesco S, Glovine D, McDowell DL, Wilson AG (1994). Novel genetic association betweenulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106: 637–642.
   PubMed Web of Science ®Google Scholar
• Mayeux R, Stern Y, Ottman R, et al (1993). The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease. Ann Neurol 34: 752–754.
   PubMed Web of Science ®Google Scholar
• McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D (1994). Variation of the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508–511.
   PubMed Web of Science ®Google Scholar
• Monforte AD, Duca PG, Vago L, Grassi MP, Moroni M (2000). Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology 54: 1856–1859.
   Google Scholar
• Mrak RE, Griffin WST (1997). The role of chronic self-propagating glial responses in neurogeneration: implications for long-lived survivors of human immunodeficiency virus. J NeuroVirol 3: 241–246.
   Web of Science ®Google Scholar
• Nadel S, Newport MJ, Booy R, Levin M (1996). Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174: 878–880.
   PubMed Web of Science ®Google Scholar
• Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B (1998). IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren’s syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87: 309–313.
   PubMedGoogle Scholar
• Plomin R, McClearn GE, Smith DL, Vignetti S, Chorney MJ, Chorney K, Venditti CP, Kasarda S, Thompson LA, Detterman DK, Daniels J, Owen M, McGuffin P (1994). DNA markers associated with high versus low IQ: the IQ quantitative trait loci (QTL) project. Behav Genet 24: 107–118.
   PubMed Web of Science ®Google Scholar
• Pociot F, Molving J, Wogensen L, et al (1992). TaqI polymorphism in the human interleukin-1β gene correlates with IL-1 beta secretion in vitro. Eur J Clin Inves 22: 396–402.
   PubMed Web of Science ®Google Scholar
• Quasney MW, Zhang Q, Sargent S, Mynatt M, Glass J, McArthur JC (2001). Increased frequency of the tumor necrosis factor-α −308 A allele in adults with human immunodeficiency virus dementia. Ann Neurol 50: 157– 162.
   Google Scholar
• Risch N, Merikangas K (1996). The future of genetic studies of complex human diseases. Science 273: 1516–1517.
   Google Scholar
• Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen BA, McArthur JC (2001). HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology 56: 257–260.
   PubMed Web of Science ®Google Scholar
• Sato-Matsumura K, Berger J, Hainfellner JA, Mazal P, Budka H (1998). Development of HIV-encephalitis in AIDS and TNF-α regulatory elements. J Neuroimmunol 91: 89–92.
   Google Scholar
• Simpson DM (1999). Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy. Clin Infect Dis 29: 19–34.
   Google Scholar
• Swindells S, Zheng J, Gendelman HE (1999). HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions. AIDS Patient Care STDs 13: 153–163.
   PubMedGoogle Scholar
• Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996). Relative risks of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 58: 574–584.
   PubMed Web of Science ®Google Scholar
• Teasdale GM, Nicoll JAR, Murray G, Fiddes M (1997). Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350: 1069–1071.
   PubMed Web of Science ®Google Scholar
• Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195– 3199.
   Google Scholar
• Zink WE, Zheng J, Persidsky Y, Poluektova L, Gendelman HE (1999). The neuropathogenesis of HIV-1 infection. FEMS Immunol Med Microbiol 26: 233– 241.
   Google Scholar